Direct healthcare cost comparison of Fluticasone propionate/Salmeterol vs Budesonide/Formoterol Maintenance And Reliever Therapy for moderate/severe asthma: Results from Thailand.

Torsak Bunupuradah,Watchara Boonsawat, Jatupum Kamrapit,Bhumika Aggarwal

Asian Pacific journal of allergy and immunology（2021）

引用 0|浏览18

暂无评分

摘要

In moderate/severe asthma patients, total direct treatment costs with regular twice-daily FP/Salm with as-needed SABA were lower than with BUD/Form MART primarily due to lower medication costs. Healthcare cost should be considered for asthma care in Thailand.

查看译文

关键词

fluticasone propionate/salmeterol,moderate/severe asthma,budesonide/formoterol

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要